Upcoming Conferences in Boston, United States

After a 17-year hiatus in drug approvals for neurodegeneration, disease-modifying drugs for AD have finally broken the ice. With Lecanemab's clinic...

2024 Course Overview This is the 38th year of our postgraduate course in Vascular and Endovascular Surgery! Providing a unique function in the CME...

As ADCs as a modality see continued clinical progress, drug developers are becoming more creative with their drug design and new analytical technol...

The development of mono- and bivalent degraders continues to gain traction, but biopharma faces challenges in rapidly discovering, validating, and ...

Pioneering the Next Breakthrough in Durable and Potent RNA Therapeutics for Patients The field of next generation RNA therapeutics continues to ...

The PEGS Boston Summit brings together leading experts at the forefront of biologics innovation, providing insights into the latest technologies, r...

Strengthening supplier and internal stakeholder collaborations, innovating in- and outsourcing models, and adopting advanced technologies to stream...

The ADC payload landscape is shifting rapidly. Driven by clinical successes of lower potency topoisomerase I inhibitors and as payloads that elicit...

The FDA Modernization Act 2.0 has triggered a new mindset for pharma, with Roche launching the Institute of Human Biology to create better models, ...

Identify Transformative ALS Targets, Seek Translational Biomarkers and Propel More Clinical Approvals Following monumental progress in 2023, the...

Following the success of the 3rd Annual Psychedelic Therapeutics and Drug Development Conference in 2023, we're thrilled to be hosting the 4th Annu...

Patient engagement is a crucial responsibility of any gene therapy company that is serious about progressing safe, effective, and meaningful therap...